Scroll Back to Top

Study number 779857

Healthy Adults, age 18-65

Dates

Apr 21 2026-Jul 01 2026

Location

Daytona Beach, Florida

Age

18-65

Gender

Male and Female

Smoker

Yes

Compensation

$12,049

Group

C2

Study Details

This is a research study for a drug approved by the U.S Food and Drug Administration (FDA) for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. This study drug is also being developed for the potential treatment of autoimmune diseases, conditions in which the immune system mistakenly attacks the body. 

Daytona Beach, FL is currently recruiting Healthy Adults, ages 18-65. 

Refer a friend & receive $350 per qualified referral

Women Eligibility Criteria

  • Women can be of childbearing potential or non-childbearing potential.

Smoking Criteria

  • Smoking is allowed. 

Body Mass Index

  • Participants must have a BMI of:
    • 18-34

Screening procedures

  • Screening procedures for this study may include:
    • Vitals
    • Physical examination
    • Electrocardiogram (ECG)
    • Collection of blood samples
    • Drug and Alcohol testing  

Additional Details

Call now to schedule your screening appointment! 

Cohort 2: 
Check-in: April 21
Check-out: April 22

Follow-up visits: April 24, 29, May 2, 6, 13, 20, Jun 3, 17, Jul 1

Phone calls: May 27, Jun 10, 24

BMI Calculator

Weight

Height

Feet Inches